期刊文献+

医院感染多药耐药菌的临床分布及耐药性分析 被引量:4

Distribution and drug resistant of multidrug-resistant bacteria for nosocomial infections
原文传递
导出
摘要 目的分析医院感染多药耐药菌的流行分布及耐药性,为临床合理用药提供科学依据,提高预防感染水平。方法对2013年6月—2014年5月的临床标本进行病原菌分离,按照《全国临床检验操作规程》进行细菌培养与鉴定;采用CLSI推荐的K-B法进行药敏实验。结果共检出病原菌518株,其中多药耐药菌138株,多药耐药菌检出率为26.64%,多药耐药菌中革兰阴性菌占81.88%(113/138),主要为大肠埃希菌、铜绿假单胞菌、鲍曼不动杆菌,分别为36.96%、16.67%、8.70%;多药耐药菌中革兰阳性菌占18.12%(25/138),主要为金黄色葡萄球菌、肠球菌属,分别为6.52%、5.80%。结论医院分离的多耐药菌革兰阴性菌占主导地位,提示临床医师应根据病原菌耐药特点,合理选择抗菌药物;加强多药耐药菌的监管,预防和减少多药耐药菌的产生。 Objective To analyze the distribution and drug resistance of multidrug-resistant bacteria causing nosocomial infections so as to guide the reasonable use of antibiotics and raise the level of infection prevention. Methods The specimens of nosocomial infection were isolated routinely from June 2013 to May 2014, the bacteria culture and identification were carred out by refering to the national clinical laboratory procedures, and the drug susceptibility testing was performed by K-B method of CLSI.Results A total of 518 strains pathogenic bacteria were isolated, among which there were 138(26.64%)strains of multidrugresistant bacteria. The isolation rate of gram-negative of multidrug-resistant bacteria was 81.88%(113/138),escherichia coli bacteria accounted for 36.96%, pseudomonas aeruginosa accounted for 16.67%, acinetobacter baumannii accounted for 8.70%. The isolation rate of gram-positive of multidrug-resistant bacteria was 18.12%(25/138), staphylococcus aureus accounted for 6.52%, enterococcus genera accounted for 5.80%. Conclusion The gram-negative bacteria are main pathogens in the multidrug-resistant bacteria isolated, which indicates that the antibiotics should be used reasonably on the basis of the species of the pathogens isolated, drug resistance. It is necessary to strengthen the monitoring of multidrug-resistant bacteria so as to prevent the emergence of drug resistant strains.
出处 《社区医学杂志》 2016年第15期14-16,共3页 Journal Of Community Medicine
基金 济宁医学院2013年科研计划项目(JY2013KJ063)
关键词 医院感染 多药耐药菌 临床分布 耐药性 Nosocomial infections Multidrug-resistant bacteria Distribution Drug resistance
  • 相关文献

参考文献8

二级参考文献46

  • 1多重耐药菌医院感染预防与控制技术指南[S].北京:中华人民共和国卫生部,2011.
  • 2医务人员手卫生规范[S].北京:中华人民共和国卫生部,2009:1-6.
  • 3CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).
  • 4European Committee on Antimicrobial susceptibility testing, Breakpoint tables for interpretation of MICs and zone diame- ters[S]. Version 2, 2012, valid from 2012-01-01.
  • 5Bush K. Alarming β-lactamase mediated resistance in multi- drug-resistant Enterobacteraceae[J]. Curr Opinion Microbi- oh 2010, 13(5): 558-564.
  • 6Nordmann P, Dortet L, Poirel L. Carbepenem resistance in Enterobacteriaceae: here is the storm! [J]. Trends Mol Med, 2012, 18(6): 263-271.
  • 7Hu FP, Chen SD, Xu XG, et al. Emergence of carbapenem resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012,61 (Ptl) : 132-136.
  • 8Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased suseep tibility to carbapenems: results from large hospital-based sur veillance studies in China[J]. Antimicrob Agents Chemoth er, 2010, 54(1):573-577.
  • 9Chen SD, Hu FP, Xu XG, et al. High prevalence of KPC-2 carbapenemase coupled with CTX-M-type extended-spectrum 13-1actamase in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China[J]. Antimierob Agents Che- mother, 2011, 55(5) :2493-2444.
  • 10Hawser SP, Bouchillon SK, Lascols C, et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infec- tions and molecular characterization of ertapenem-resistant i- solates[J]. Antimicrob Agents Chemother, 2011, 55 (8) : 3917-3921.

共引文献497

同被引文献65

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部